Today, Invivoscribe and Complete Genomics announced a comprehensive partnership to transform oncology and cancer research around the world. The two companies have combined forces to … Read more

AOP Health has made an important advancement reinforcing its clinical development program for ropeginterferon alpha-2b (BESREMi®) in polycythaemia vera (PV), a rare blood cancer. This … Read more

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company dedicated to unlocking the potential of oral, small molecule protease inhibitors, announced its multiple abstracts … Read more

BioNTech SE and OncoC4, Inc. are thrilled to announce preliminary data from a Phase 1/2 trial showing promising clinical anti-tumor activity for their anti-CTLA-4 antibody … Read more

Hemogenyx Pharmaceuticals plc (LSE:HEMO) has received a clinical hold notice from the U.S. Food and Drug Administration in regard to their Investigational New Drug application … Read more

Today, Senseonics Holdings, Inc. – a medical technology company that develops and manufactures long-term and implantable continuous glucose monitoring (CGM) systems – announced some exciting … Read more

Affini-T Therapeutics, Inc., a precision immunotherapy company transforming the field of cancer treatment, is proud to welcome Thaminda Ramanayake as Chief Business Officer. With over … Read more

Today Foundation Medicine, Inc., has unveiled the launch of its cutting-edge ctDNA monitoring assay, FoundationOne®Monitor – available for research use in retrospective studies. FoundationOne Monitor … Read more

Illumina, Inc. (NASDAQ: ILMN), a pioneer in cutting-edge DNA sequencing and array-based technologies, today unveiled plans to maximize shareholder value over the long term through … Read more

MEI Pharma, Inc. (NASDAQ: MEIP) has announced that Daniel P. Gold, Ph.D. will conclude his tenure as the president and chief executive officer of MEI … Read more

Myriad Genetics, Inc. (NASDAQ: MYGN) strengthens its commitment to the future of precision medicine with the appointment of renowned oncologist Adam Brufsky, MD, PhD, FACP … Read more

Tenax Therapeutics, formerly known as Oxygen Biotherapeutics, Inc., has been granted a Notice of Allowance by the USPTO for its patent application that covers the … Read more

Fate Therapeutics, Inc., the clinically-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer … Read more

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) is excited to announce that John Celebi, President & Chief Executive Officer, will be presenting at the renowned Jefferies Global … Read more

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) announced that its management team will be participating in the Jefferies Healthcare Conference, and is excited to share their vision for … Read more

Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) is gearing up to give a live Fireside Chat at the Jefferies Healthcare Conference on June 8th at 10:30am ET. … Read more

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an innovative clinical-stage oncology company and leader in pioneering novel-format antibody drug conjugates (ADCs), announced that … Read more

Cocrystal Pharma, Inc. (Nasdaq: COCP) is thrilled to announce that they have been granted approval from the Australian Human Research Ethics Committee (HREC) to initiate … Read more

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) is thrilled to announce that it will be participating in the Jefferies Healthcare Conference in New York City on June … Read more

Today, Armis Biopharma, Inc. announced a major breakthrough – the VeriCyn® Wound Wash medical device, now cleared by the U.S. Food and Drug Administration (FDA). … Read more

ValnevaSE, a specialty vaccine company, is pleased to invite shareholders and other interested parties to attend its Combined General Meeting on June 21, 2023 at … Read more

Cellular Origins, a TTP Company pioneering a new era of scalable, cost-effective and space-efficient cell and gene therapies (CGTs) manufacturing, is proud to present the … Read more

Alvotech, a leading global biotech company dedicated to the development and production of pioneering biosimilar medicines, is excited to announce their participation at the Jefferies … Read more

ValnevaSE, a specialty vaccine company, will have senior members of its team in the U.S. and France to take part in some of the highest-profile … Read more

Ostentus Therapeutics, Inc. has taken a bold step forward in the fight against cancer by entering into a second Sponsored Research Agreement with City of … Read more

Yuhan Corporation (CEO, Wook-Je Cho), on May 30th, unveiled an exciting in-license agreement with J INTS BIO (CEO,Anna Jo). Worth $325 million in total, the … Read more

IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) is excited to announce that its Phase IIb study of pirepemat (IRL752) is now recruiting patients at 38 … Read more

Anocca AB is thrilled to announce that it has successfully raised an incredible SEK 400 million through an equity financing round led by AMF and … Read more

Sanofi’s innovative second-generation investigational anti-CD40L antibody, Frexalimab, has astounded experts in the field by significantly reducing disease activity in patients with relapsing multiple sclerosis (MS). … Read more

Today, Ascentage Pharma, a global biopharmaceutical company focused on developing therapies for cancer, CHB, and age-related diseases, received some fantastic news. The Center for Drug … Read more

On June 20th, 2023, Relief Therapeutics proudly invites its shareholders to its Annual General Meeting held at the gorgeous avenue de Sécheron 15 in Geneva, … Read more

Join Bridge Biotherapeutics Inc. (KQ288330) at the 2023 BIO International Convention in Boston, Massachusetts on Tuesday, June 6, as Director of Business Development Pavel Printsev … Read more

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”) announced that it has teamed up with Charles River to conduct a GLP toxicology study … Read more

Titan Medical Inc. (TSX: TMD; OTC: TMDIF) today provided a corporate update and also offered an update on their current default status in accordance with … Read more

Roche Canada is thrilled to announce that negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) have come to a successful conclusion. VABYSMO® (faricimab injection) is now … Read more

AbCellera is taking the stage! Executives from the Company will be presenting at the highly anticipated Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, … Read more

At its Annual Meeting of Shareholders held on May 29, 2023, Extendicare Inc. (TSX: EXE) – or the Company – saw all the nominees listed … Read more

Today, iNtRON Biotechnology is thrilled to announce the discovery of Prophage and (non-) ORF-Jamphage from the microbiome commonly found in long-term Pancreatic cancer survivors. This … Read more

AstriVax is delighted to have received a €2.5 million grant from Flanders Innovation & Entrepreneurship (VLAIO) in support of their revolutionary technology. This exciting development … Read more

Novotech, the premier Asia Pacific centred biotech CRO is proud to sponsor the BIO 2023 APAC Summit, and its session on Forging New Biotech Ties … Read more

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Experience an amazing … Read more

Schrödinger, a revolutionary innovator in physics-based computational technology, will be featured in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023. … Read more

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a leader in the development of innovative therapies to treat seizure disorders, is proud to announce that the European Medicines … Read more

Ferring Pharmaceuticals and its clinical development partner, Seikagaku Corporation, have achieved a major milestone in their clinical trials of SI-6603. After positive topline results in … Read more

Biodynamic Technologies is delighted to announce a pioneering breakthrough in the early detection of pancreatic pre-cancer lesion – as detailed in their newly published case … Read more

At the 2023 ASCO Annual Meeting in Chicago, USA, Abbisko Therapeutics Co., Ltd. is set to reveal the latest findings of their Phase Ib clinical … Read more

At the ISID 2023 Tokyo Satellite Meeting, collaborators from Keio University and Osaka University showcased groundbreaking findings from a murine model of pemphigus. Through the … Read more

Amplia Therapeutics Limited (ASX: ATX) is thrilled to announce the outstanding results of AMP945, its investigational FAK inhibitor, when used in combination with FOLFIRINOX in … Read more

Hummingbird Bioscience is paving the way for groundbreaking, cutting-edge treatments with its upcoming presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in … Read more

Harbour BioMed, a global biopharmaceutical firm dedicated to the discovery, development, and commercialization of revolutionary antibody treatments, has recently unveiled the outcomes of the phase … Read more

Innate Pharma SA is proud to announce that the latest research concerning its SAR443579 drug’s benefits for relapsed or refractory acute myeloid leukemia, B-cell acute … Read more

Gilead Sciences, Inc. (Nasdaq: GILD) announced exciting news today regarding its antiviral treatment Veklury (remdesivir). It has received a positive opinion from the Committee for … Read more

Occlutech Holding AG is an innovative pioneer in the medical device industry, providing minimally invasive structural heart implants to 85 countries around the world. By … Read more

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the upcoming departure of Chief Financial Officer (CFO) Yafei (Roxi) Wen. Ms. Wen will step … Read more

Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS), a clinical-stage biotechnology company dedicated to developing therapeutics that combat the degenerative effects of aging, has submitted an application for … Read more

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company on a mission to uncover and develop targeted therapeutics, today announced a major grant of … Read more

Antengene Corporation Limited (SEHK: 6996.HK), a pioneering global biopharmaceutical company, is thrilled to announce that the newest findings from its Phase I/II TORCH-2 study have … Read more

Castellum, Inc., a leading cybersecurity and electronic warfare services provider serving Federal Government clients, is taking the bold step of committing to a major cost … Read more

In February 2023, responding to Japanese Prime Minister Fumio Kishida’s goal to develop the domestic cultivated food industry, the Japan Association for Cellular Agriculture (JACA) … Read more

Genexine, a Korean biopharmaceutical company dedicated to the production of life-saving treatments, has announced the publication of their groundbreaking phase 2 clinical trial data in … Read more

On June 7-9, 2023, NeuBase Therapeutics, Inc. (Nasdaq: NBSE) will be showcasing their Stealth Editors™ at the Jefferies Healthcare Conference at the Marriott Marquis in … Read more

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) is taking a major step forward in the fight against Alport syndrome – a rare genetic disease – with the … Read more

Pliant Therapeutics, Inc. (Nasdaq: PLRX) is thrilled to present exciting data from its Phase 2a clinical trials and preclinical studies on bexotegrast (PLN-74809), its novel … Read more

Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company dedicated to revolutionizing the way we take our medication, proudly announces the appointment of Kate McKinley as … Read more

Lisata Therapeutics, Inc. (Nasdaq: LSTA) is continuing their ASCEND trial, aPhase 2b trial investigating their investigational drug, LSTA1, when paired with the standard-of-care gemcitabine/nab-paclitaxel in … Read more

Immutep Limited (ASX:IMM; NASDAQ:IMMP), a clinical-stage biotechnology company developing innovative LAG-3 immunotherapies for cancer and autoimmune diseases, is excited to share new promising clinical data … Read more

Spectral Medical Inc. (TSX: EDT) recently hosted an investigator meeting in Charlotte, North Carolina on May 17 to 18, 2023. This in-person event was attended … Read more

Azenta, Inc. (Nasdaq: AZTA) has been chosen by The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics to revolutionize lupus research and drug … Read more

Ambrx Biopharma Inc. (NASDAQ: AMAM) is pleased to announce the completion of its registered direct offering with clients managed by Darwin Global Management Ltd., which … Read more

Palisade Bio Inc. (Nasdaq:PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, recently announced an update to its clinical program for its … Read more

Halberd Corporation (OTC PINK:HALB) has made huge strides towards its groundbreaking nasal spray to combat Traumatic Brain Injury (TBI). After initial preclinical phase testing by … Read more

Talis Biomedical Corporation (Nasdaq: TLIS), a leading diagnostics company committed to delivering accurate disease testing at the point of care, has taken two important steps … Read more

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is making strides in the research and development of cardiometabolic disease treatments with the full data from their ROSE2 … Read more

T2 Biosystems Inc. (NASDAQ:TTOO) has skyrocketed to the forefront of early detection of dangerous sepsis-causing pathogens and antibiotic resistance genes with their newly submitted T2Biothreat™ … Read more

Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT) is pleased to announce that it has signed a definitive agreement to offer for sale a total of 3,256,269 … Read more

Theralink Technologies, Inc. (OTC: THER) and IMAC Holdings, Inc. (Nasdaq: BACK) have joined forces in a groundbreaking stock-for-stock reverse merger transaction, which will create an … Read more

At Avalyn Pharma Inc., safety and tolerability of AP01 (inhaled pirfenidone), an experimental inhaled drug candidate in development for the treatment of pulmonary fibrosis, was … Read more

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company dedicated to developing and commercializing groundbreaking therapies for the treatment of liver and cardiometabolic diseases, is proud … Read more

Ocean Biomedical (NASDAQ: OCEA) is proud to announce a major breakthrough in cancer immunotherapy! Its Scientific Co-founder, Dr. Jack A. Elias, MD, has recently been … Read more

T2 Biosystems Inc. (NASDAQ:TTOO), a leading innovator in the fight against sepsis, is taking a bold move to maximize value through a strategic alternatives process. … Read more

AnaMar, a clinical-stage biotech revolutionizing the treatment of systemic sclerosis (SSc), has just announced remarkable results from its Phase I trial with AM1476, their first-in-class, … Read more

This year, OMRON Healthcare Co., Ltd. celebrates 50 years of producing the world’s most accurate and consumer-friendly blood pressure monitors. With more than 350 million … Read more

LUND, Sweden– On May 23, 2023, the world witnessed a remarkable breakthrough engineered from the European nation of Sweden. After years of dedicated research, scientists … Read more

Carmot Therapeutics, Inc., a clinical-stage biotechnology company, is thrilled to be participating in the American Diabetes Association Annual Meeting from June 23–26, 2023 in San … Read more

Spago Nanomedical AB (publ) is thrilled to announce the upcoming commencement of its clinical phase I/IIa trial, Tumorad-01, utilizing its leading drug candidate 177Lu-SN201. After … Read more

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, is excited to announce the pricing of their public offering showcasing 1,896,286 shares of their common … Read more

Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company, is pleased to announce the successful pricing of a highly anticipated underwritten public offering of 12,500,000 … Read more

Today, Propanc Biopharma, Inc. (OTC Pink: PPCB) announced an exciting development for its stakeholders: the board of directors has approved a reverse stock split of … Read more

BioMimetix, a cutting-edge medtech company developing biomorphic programmable polymers for tissue reconstruction, has just announced the closure of its Series D round, raising an impressive … Read more

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) is pleased to announce that members of its senior management team will be speaking at a series … Read more

Daxor Corporation (Nasdaq: DXR) is proud to announce the pricing of its underwritten public offering of 410,260 shares of common stock at $9.75 per share. … Read more

Panbela Therapeutics Inc. (Nasdaq: PBLA) is thrilled to announce it has taken a bold step forward in treating patients with STK11 mutant non-small cell lung … Read more

Coherus BioSciences, Inc. (Nasdaq: CHRS), is proud to introduce its revolutionary single-dose, prefilled UDENYCA® (pegfilgrastim-cbqv) autoinjector to the United States market. UDENYCA® is an incredibly … Read more

The FDA has accepted the Premarket Approval application for Lumicell™ Direct Visualization System, allowing for a revolutionary imaging technique that provides clear visualization of cells … Read more

Yaral Pharma, the US generics subsidiary of IBSA, is proud to partner with Eversana®, a leader in global life sciences services to help broaden its … Read more

Boehringer Ingelheim Pharmaceuticals, Inc. is pleased to announce that the U.S. Food and Drug Administration has granted approval for the launch of the all-new Cyltezo … Read more

On Monday, May 22, 2023, NanoString Technologies, Inc. (NASDAQ:NSTG) will be hosting an informative conference call at 4:30pm ET to discuss a noteworthy ruling in … Read more

As we mark Gout Awareness Day on May 22, 2023, Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., a clinical stage biotechnology company, is calling for … Read more

Kelyniam Global (OTC: KLYG), a pioneer in custom cranial implants, has released its financial report for the quarter ending March 31, 2023. The company continues … Read more

Eisai, the partner of BioArctic AB’s (publ), an emerging life sciences company listed on NASDAQ Stockholm, has just taken a major step towards realizing their … Read more

Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) has taken action to further its vision of developing groundbreaking cell and gene therapies to combat … Read more

The three-judge panel of Louisiana’s 5th Circuit Court of Appeal grilled the Food and Drug Administration (FDA) during Wednesday’s oral arguments, pressing for details on … Read more

AstraZeneca signed a non-exclusive deal with Massachusetts biotech Revvity on Thursday to gain access to their exclusive gene-editing technology, which will be used to develop … Read more

The U.S. Supreme Court has delivered a long-anticipated victory to pharmaceutical giants Sanofi and Regeneron, ruling unanimously in their favor in a decade-long battle with … Read more

A potential breakthrough in pediatric health care is on the horizon, as the FDA reviewed documents from Pfizer that suggest their experimental Abrysvo vaccine against … Read more

Agilent Technologies Inc. (NYSE: A) today stated its intention to challenge the ruling of the U.S. Patent and Trademarks Office’s (USPTO) Patent Trial and Appeal … Read more

Sobi has announced exciting news – the European Medicines Agency (EMA) has officially accepted and validated their application for the revolutionary treatment efanesoctocog alfa for … Read more

CorFlow Therapeutics AG, a clinical-stage company pioneering combined diagnosis and therapy systems for coronary microvascular obstructions (MVO), presented interim positive results from its MOCA I … Read more

Humanetics Biomed is an innovative Contract Development Manufacturing Organisation (CDMO) that utilises the latest biomedical technologies and precise lasered components and subcomponents from Humanetics to … Read more

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pioneering pharmaceutical company striving to innovate a robust portfolio of small molecule candidate drugs for the treatment of … Read more

At the Protein Engineering Summit (PEGS) and at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in Los Angeles, Orna Therapeutics presented … Read more

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK) has launched a new clinical trial in the U.S. to test the effectiveness of its innovative CAR T-cell … Read more

SiteOne Therapeutics, Inc. has just received a $15 million grant from the National Institute on Drug Abuse as part of the NIH HEAL Initiative, a … Read more

Xtant Medical Holdings, Inc. (NYSE American: XTNT) is delighted to announce the appointment of Lori Mitchell-Keller to its Board of Directors, effective May 16, 2023. … Read more

IQVIA Holdings Inc. (NYSE:IQV), a wholly-owned subsidiary of IQVIA Inc., has announced plans to raise $1 billion dollars through an offering of senior secured notes … Read more

Myeloid Therapeutics, Inc., a clinical stage mRNA-immunotherapy company, announced today the successful completion of an impressive $73 million financing round. The investment was led by … Read more

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its oral health care division, OraPharma, Inc., have recently published the results of a new study which showed that … Read more

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) has published groundbreaking findings from the CAMEO study in the journal Hepatology Communications, providing new insights into the safety, tolerability, … Read more

HeartBeam, Inc. (NASDAQ: BEAT), a groundbreaking cardiac technology company, has taken an incredible step forward in the medical industry today with the submission of a … Read more

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company dedicated to developing innovative biotherapeutics, has announced the departure of Neil Klompas, President and Chief Operating Officer. … Read more

Thermo Fisher Scientific Inc. (NYSE: TMO) today released its 2020 Corporate Social Responsibility (CSR) report to showcase its ongoing commitment to society and stakeholders. The … Read more

Biocept, Inc. (Nasdaq: BIOC) is proud to announce that its 1-for-30 reverse stock split became effective at 4:05 p.m. Eastern Time on May 16, 2023 … Read more

Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, is excited to announce that the U.S. Food and Drug Administration (FDA) … Read more

Verismo Therapeutics, a clinical-stage CAR T company, Penn spinout, and leader in the development of the innovative KIR-CAR platform technology, is thrilled to welcome Sara … Read more

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) is proud to announce the appointment of Brian Cogley, MBA, as the new Chief Financial Officer (CFO). With 15 … Read more

ImmunoBrain Checkpoint Inc. (IBC), a pioneering biopharmaceutical company creating cutting-edge disease-modifying immune therapies to fight neurodegenerative diseases, has just administered its first two dosages of … Read more

STRM.BIO, a pre-clinical biotechnology company pioneering gene therapies utilizing extracellular vesicles (EVs) to treat rare blood diseases, today announced the appointment of Dawn Bell, PharmD … Read more

Evox Therapeutics Ltd, a pioneering exosome therapeutics company, is proud to announce that the US Patent and Trademark Office has granted the Company another patent … Read more

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, recently unveiled impressive preclinical data at the American Society of Cell … Read more

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced today that the U.S. Food and Drug Administration (FDA) has approved an amendment to the Phase 1/2 study of … Read more

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) is pleased to announce the appointment of Lisa Rojkjaer, M.D., as the company’s new Chief Medical Officer. An esteemed leader … Read more

Immutep (formerly known as Prima Biomed) Limited (ASX: IMM; NASDAQ: IMMP) is thrilled to announce it has received a positive response from the US Food … Read more

YS Biopharma, a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer, … Read more

Ray Therapeutics, a pioneering optogenetics company, has announced an oversubscribed $100M Series A financing round backed by some of the world’s most influential investors. Novo … Read more

Regulus Therapeutics, Inc. (Nasdaq: RGLS) is thrilled to announce that it is progressing to the second cohort of patients in the Phase 1b MAD study … Read more

Milestone Scientific, Inc. (NYSE:MLSS) is thrilled to announce that its revolutionary CompuFlo® Epidural disposables have been met with great success in Torrance, California. After a … Read more

Chinook Therapeutics, Inc. (Nasdaq: KDNY) and Ionis Pharmaceuticals, Inc. have joined forces to develop a cutting-edge antisense oligonucleotide (ASO) therapy to treat a rare, severe … Read more

Biocoat, Inc., a leading manufacturer of hydrophilic biomaterial coatings and coating equipment for medical devices, is pleased to announce the appointment of Gregory (Greg) Santorno … Read more

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR) has just announced a major investment victory for its future! The leading discovery and development company for novel small molecule … Read more

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP), a clinical stage biopharmaceutical company developing a groundbreaking new class of antibiotics for difficult-to-treat bacterial infections, has announced that it … Read more

Potrero Medical, Inc., innovator of the Accuryn Monitoring System, is proud to announce that Maclean Health has been appointed as its Exclusive Distributor of Record … Read more

Nusano, Inc. and PharmaLogic have joined forces to revolutionize the production of cancer-fighting radioisotopes, creating innovative radiopharmaceuticals for diagnostic and therapeutic purposes. As a world-class … Read more

Gracell Biotechnologies Inc. (NASDAQ: GRCL), a global biopharmaceutical company dedicated to revolutionizing the treatment of cancer and autoimmune diseases, is delighted to announce the launch … Read more

Rona Therapeutics, Inc and Keymed Biosciences are teaming up to launch a groundbreaking collaboration to create the first-ever siRNA therapeutics for Glomerulonephritis, a severe kidney … Read more

Avantor Performance Materials, Inc. (NYSE: AVTR) announced today that Executive Vice President and Chief Financial Officer Thomas A. Szlosek will be leaving the Company effective … Read more

Dante Genomics, a pioneering force in genomics and precision medicine, is introducing a groundbreaking feature to its AVANTI Software—free of charge! This platform agnostic software … Read more

ImmPACT Bio, a clinical-stage company developing groundbreaking CAR T-cell therapies for cancer and autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) … Read more

Ikena Oncology, Inc. (Nasdaq: IKNA) is forging a new path in patient-directed cancer treatment with the pricing of an underwritten offering of 6,110,000 shares of … Read more

Therini Bio, Inc., a biotech company dedicated to researching and developing fibrin-targeted therapies, is ushering in a new era of medical treatments with the start … Read more

Today, Juno Pharmaceuticals Canada (“Juno”) has taken a major step forward in the commercialization of specialty pharmaceuticals, with the acquisition of Omega Laboratories (“Omega”) – … Read more

The FDA’s Nonprescription Drugs Advisory Committee and Obstetrics, Reproductive and Urologic Drugs Advisory Committee have given their unanimous go-ahead for Perrigo’s birth control drug, Opill … Read more

Mirion Technologies, Inc. (NYSE: MIR), a global leader in radiation detection, measurement, analysis, and monitoring solutions for the medical, nuclear, defense, and research sectors, today … Read more

Cellectis, a clinical-stage biotechnology company using its groundbreaking gene-editing platform to develop revolutionary cell and gene therapies, recently revealed the impressive results of its TALEN® … Read more

The Company is pleased to announce the appointment of Professor Solange Peters as an Independent Non-executive Director, member of the Technical Committee and member of … Read more

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) has announced the sale of shares of AmerisourceBergen Corporation (NYSE: ABC) common stock through a series of variable prepaid … Read more

The Beijing Puhui Health Insurance Program has added an imported version of Nefecon (budesonide) delayed release capsule to its 2023 New Reimbursement Drug List of … Read more

At ESMO Breast Cancer Congress 2023 in Berlin, Veracyte, Inc. (Nasdaq: VCYT) presented new findings from EMIT, a multi-year, population-based study in Norway. The data … Read more

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company, has announced the impressive results from their Phase 1b trial of gedatolisib, a pan-PI3K/mTOR inhibitor, in combination with … Read more

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is pleased to announce its participation in the upcoming Lytham Partners Spring 2023 Investor Conference. The virtual event will … Read more

IntraOp Medical Corporation has made history with the successful launch of the world’s first Phase II Electron FLASH Trial. This trial is a groundbreaking advancement … Read more

ExtendBio, the clinical stage biopharmaceutical company developing advanced therapeutic peptides, today announced positive results from its first-in-human trial of EXT608. The interim analysis indicated that … Read more

Bicycle Therapeutics Limited (NASDAQ: BCYC) and Orano Med have announced remarkable pre-clinical results for Pb-BCY20603, their innovative Bicycle® radio-conjugate (BRC™). This BRC™ binds to the … Read more

CovationBio™—a renowned biomaterials firm known for its Sorona®, Susterra®, and Zemea® propanediol offerings—has unveiled its inaugural sustainability report less than one year after becoming an … Read more

Lumen Bioscience, a clinical-stage biotechnology company, has been awarded an $8.8 million project by the United States Department of Defense (DOD) to develop and test … Read more

SERB Pharmaceuticals and SFJ Pharmaceuticals proudly announce a groundbreaking development in the pharmaceutical realm: SERB has acquired exclusive US rights to the ticagrelor reversal agent … Read more

Cytokinetics, Inc. (Nasdaq: CYTK) is excited to announce that the first participants have been successfully dosed in a Phase 1 clinical study of CK-4021586 (CK-586)! … Read more

Tesis Biosciences has revolutionized the way we identify genetic mutations associated with Covid-19 risk. Their groundbreaking new test utilizes targeted genetic sequencing to pinpoint the … Read more

Angelini Pharma and JCR Pharmaceuticals Co., Ltd. (TSE 4552) have joined forces to develop and commercialize cutting-edge biologic therapies that use J-Brain Cargo®, a revolutionary … Read more

Cellular Origins, a TTP Company specializing in cost-effective, efficient, and scalable cell and gene therapy (CGT) manufacture, is teaming up with ScaleReady—a joint venture of … Read more

Today, Soligenix Inc. (Nasdaq: SNGX) announced that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to discuss the design of … Read more

Transgene (Euronext Paris: TNG), a pioneering biotech firm leading the way in cancer treatments, has announced that their first patient has been dosed in the … Read more

Cerevel Therapeutics, a leader in neuroscience research, is pleased to announce the appointment of Susan Altschuller, Ph.D. as its new Chief Financial Officer. Dr. Altschuller … Read more

SwiftBio Therapeutics, a gene therapy research and development company, has conducted a healthcare resource use study on the devastating effects of AMN (adrenomyeloneuropathy). The study … Read more

Addex Therapeutics, a leader in allosteric modulation-based drug discovery and development, has announced that an Independent Interim Review Committee (IRC) has recommended the continuation of … Read more

HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:​HCM, HKEX:​13) is delighted to announce that Professor Solange Peters has been appointed as an Independent Non-executive Director, … Read more

Alvotech, a global biotech company dedicated to developing and producing biosimilar medicines for patients worldwide, is proud to announce a new exclusive agreement with Polifarma … Read more

Ribbon Biolabs, a leader in the field of DNA synthesis, is pleased to welcome Jodi Barrientos as its new Chief Business Officer. With over 17 … Read more

CTI BioPharma (Nasdaq: CTIC) has entered into a definitive agreement with Swedish Orphan Biovitrum AB (STO: SOBI) to be acquired in an all-cash transaction worth … Read more

At the 4th Annual Dermatology Drug Development Summit Europe on May 22-24, 2023, in Berlin, Germany, UNION therapeutics A/S (UNION) CEO Dr. Kim D. Kjøller … Read more

FE Inc., a cutting-edge microfluidics company focused on revolutionizing the development and production of advanced cell therapies, is proud to announce the launch of its … Read more

Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) is thrilled to announce its recent filing for a pre-submission meeting with the European Medicine Agency (EMA) to discuss the … Read more

Ochre Bio, a leader in the development of treatments for chronic liver disease, is taking part in upcoming investor and industry conferences to deliver expert … Read more

Novotech, the premier Asia Pacific-based biotech CRO, teamed up with Citeline to conduct a survey among global biotech professionals, seeking to gain insights into their … Read more

On April 22, Neuboron Medical Group (NMG), a leading global Accelerator-based Boron Neutron Capture Therapy (AB-BNCT) total solution provider, and Xiamen Humanity Hospital (XHH) joined … Read more

Engitix Ltd, a biotechnology company pioneering the use of its proprietary human extracellular matrix (ECM) platform for drug discovery across fibrosis and solid tumours, is … Read more

BioNxt Solutions Inc. is thrilled to announce the successful completion of a human pilot study for a top European-based generic drug company. BioNxt proudly developed … Read more

Interius BioTherapeutics, a preclinical stage gene therapy company, has announced a manufacturing partnership with WuXi Advanced Therapies (WuXi ATU) to bring its innovative INT-2104 gene … Read more

BellaSeno GmbH, an ISO 13485-certified medtech company with a cutting-edge approach to additive manufacturing technologies, has just reported highly encouraging interim results from two clinical … Read more

SphingoTec has achieved a major milestone, having been re-certified according to ISO 13485 and receiving its first IVDR certificate for its IVD product sphingotest® penKid®. … Read more

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) is pleased to announce the total number of shares outstanding and voting rights … Read more

MindBio Therapeutics Corp. (CSE: MBIO) is thrilled to announce that its common shares have officially listed on the Canadian Securities Exchange, under the ticker symbol … Read more

ACG is delighted to have been shortlisted as a contender for Global Water Intelligence’s Industrial Project of the Year Award. Since its inception in 2006, … Read more

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company committed to developing and commercializing novel treatments for rare and ultrarare genetic diseases, is proud to announce … Read more

Arcutis Biotherapeutics, Inc., a leading biopharmaceutical company with a focus on creating meaningful innovations in immuno-dermatology, is pleased to announce the grant of 84,000 restricted … Read more

Fulcrum Therapeutics, Inc.® (Nasdaq: FULC) is thrilled to announce that it has granted non-statutory stock options to new employees, underscoring its commitment to improving the … Read more

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) has successfully concluded its Rights Offering which expired on April 27, 2023. The Company raised a … Read more

Science 37, Inc. (Nasdaq: SNCE) – the industry-leading Metasite™ – has granted equity awards to non-executive employees as part of its 2022 Employment Inducement Incentive … Read more

Chinook Therapeutics, Inc. (Nasdaq: KDNY) recently announced the approval of new employment inducement grants of stock options and restricted stock units to eleven new employees. … Read more

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on addressing unmet medical needs in oncology, autoimmune diseases, and infectious … Read more

Novo Nordisk’s hopes for concizumab as a prophylactic treatment for hemophilia A and B were dashed on Thursday, when the FDA rejected their application for … Read more

Catalent, Inc. (NYSE: CTLT) has been notified of an unsolicited “mini-tender offer” by TRC Capital Investment Corporation (“TRC”) to purchase up to 2,000,000 shares of … Read more

At its 2023 Annual General Meeting, Alcon Inc. (SIX/NYSE: ALC) – the world’s top eye care provider – made a groundbreaking announcement: all proposed resolutions … Read more

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is thrilled to announce the approval of an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan … Read more

Amador BioSciences is proud to welcome Dr. Lorin Roskos as its new Chief Scientific Officer and President of Quantitative Clinical Pharmacology (QCP). With extensive experience … Read more

Jaguar Health Inc. (NASDAQ:JAGX) recently granted two new employees a combined total of 4,100 restricted stock units (RSUs). New Employee 1 was granted 100 RSUs, … Read more

Glaukos Corporation (NYSE: GKOS), a leader in ophthalmic medical technology and pharmaceuticals, has received the “Day 74” notification from the U.S. Food and Drug Administration … Read more

Mereo BioPharma Group plc (NASDAQ: MREO) is thrilled to announce that the Listing Qualifications Department of the Nasdaq Stock Market has granted approval for the … Read more

ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, is pleased to announce that on … Read more

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) recently welcomed 44 new employees with a generous incentive package! On April 24, 2023, the Compensation Committee of Acadia’s Board … Read more

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company devoted to finding treatments for rare respiratory diseases, has just granted inducement awards to two of … Read more

Kalos Medical, Inc., a developer of revolutionary and minimally invasive medical devices, has been selected to participate in the 2023 Industrial Technology Innovation Project. This … Read more

STERIS plc (NYSE: STE) is delighted to announce the addition of Esther M. Alegria, Ph.D. to its Board of Directors, effective immediately. Dr. Alegria brings … Read more

Join us on Wednesday, May 10, 2023 at 5:00 pm ET (2:00 pm PT) for OraSure Technologies, Inc.’s exciting earnings conference call! Learn about the … Read more

Xenetic Biosciences, Inc. (NASDAQ:XBIO) is thrilled to announce the engagement of Scott N. Cullison as an executive consultant for business development. Mr. Cullison will be … Read more

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology, has achieved a major milestone with the … Read more

Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.08 per share for the quarter … Read more

At the LSX World Conference 2023, Rubedo Life Sciences, a biopharmaceutical company dedicated to fighting chronic age-related diseases, proudly announced the selection of RLS-1496 as … Read more

Veracyte, Inc. (Nasdaq: VCYT) today unveiled its inaugural Environmental, Social and Governance (ESG) Report, setting the course for the company’s ESG performance for the years … Read more

Summit Therapeutics Inc. (NASDAQ: SMMT) is thrilled to announce that it has identified two indications in non-small cell lung cancer (NSCLC) where its innovative, potential … Read more

RAPT Therapeutics, Inc., a clinical-stage immunology-focused therapeutics company dedicated to discovering, developing, and commercializing oral small molecule therapies for patients in need of innovative treatments … Read more

Spesana is delighted to introduce its newly formed Advisory Board, made up of industry experts from clinical sites, life science companies, and diagnostic labs. This … Read more

CRISPR Therapeutics, a biopharmaceutical company dedicated to developing groundbreaking gene-based medicines to treat serious diseases, is proud to announce that members of its senior leadership … Read more

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN), a company dedicated to developing treatments for severe neurodegenerative diseases, has announced promising preliminary results from a new biomarker study … Read more

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical leader in the research and commercialization of therapeutics for central nervous system (CNS) disorders, is excited to announce … Read more

Strata Oncology, Inc., a revolutionary precision oncology company that is revolutionizing cancer treatment, has been honored with an honorable mention in the health category of … Read more

Integer Holdings Corporation (NYSE: ITGR) is delighted to announce their participation in the 2023 Bank of America Securities Healthcare Conference in Las Vegas, Nevada. This … Read more

On his exciting trade mission trip to Israel, Florida Governor Ron DeSantis announced a groundbreaking agreement between Florida Atlantic University and Insightec – a global … Read more

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company dedicated to developing treatments for patients with RAS/MAPK pathway-driven cancers, will be featured in a fireside … Read more

Science 37 Holdings, Inc. (Nasdaq: SNCE) is excited to announce its partnership with the Digital Medicine Society (DiMe) and Moffitt Cancer Center as part of … Read more

Conventus Flower Orthopedics, a pioneering medical technology company focused on driving innovation, is pleased to welcome Anjan R. Shah, MD as its new Chief Medical … Read more

CinDome Pharma, a CinRx portfolio company, is excited to present a poster at the 2023 Digestive Disease Week (DDW) Conference in Chicago, Illinois. Titled “Effect … Read more

Quantum-Si Incorporated (Nasdaq: QSI), The Protein Sequencing Company™, is pleased to announce the appointment of Jeff Keyes as its new Chief Financial Officer, effective May … Read more

Alloy Therapeutics, a biotechnology ecosystem company, is proud to announce a new collaboration with Lundbeck, a global pharmaceutical powerhouse specializing in brain diseases. Together, they … Read more

Horizon Therapeutics plc (Nasdaq: HZNP) has been ranked first in patient centricity, integrity, ease of relations and transparency in pricing by patient groups who worked … Read more

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) is proud to announce the successful completion of a private placement of its securities with Rafael Holdings, Inc. (NYSE:RFL). The … Read more

Bryn Pharma, LLC, a privately held pharmaceutical company on a mission to provide patients and caregivers a better way to treat anaphylaxis, is proud to … Read more

Olympus Corporation, a leader in medical and surgical procedure innovation, is proud to announce the FDA clearance of the EVIS X1 endoscopy system, along with … Read more

Amit Etkin, M.D., Ph.D., founder and chief executive officer of Alto Neuroscience, Inc., was recently named a finalist for the prestigious Entrepreneur Of The Year® … Read more

Scorpion Therapeutics, Inc. is proud to announce that the first patient has been dosed in their Phase 1/2 first-in-human clinical trial to evaluate the efficacy … Read more

argenx (Euronext & Nasdaq: ARGX), a pioneering global immunology company devoted to improving the lives of those suffering from severe autoimmune diseases, will be hosting … Read more

Aquavit Holdings is thrilled to announce the filing of its Investigational New Drug Application with the FDA for its revolutionary intradermal injection of botulinum toxin, … Read more

Promis Diagnostics, Inc. is proud to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to EarlyTect BCD, an innovative … Read more

Nuvo Group Ltd., the creators of INVU by Nuvo™ – a revolutionary and FDA-cleared remote pregnancy monitoring platform – and LAMF Global Ventures Corp I … Read more

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950) made a major breakthrough in the treatment of hypertrophic scars, as the company announced positive headline results of its phase … Read more

Intuitive (NASDAQ: ISRG), a global leader in minimally invasive care and innovator of robotic-assisted surgery, is pleased to announce that the Food and Drug Administration … Read more

Prothena has recently partnered with Walgreens to accelerate the process of enrolling patients in a clinical trial for an anti-amyloid antibody that could revolutionize the … Read more

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is pleased to announce that its next-generation topical PDE4 inhibitor therapy for plaque psoriasis, ZORYVE™ (roflumilast) cream 0.3%, has officially … Read more

GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, has announced that its board of directors has approved a 1-for-33 reverse … Read more

Cartherics Pty Ltd, a biotechnology company that is revolutionizing the way cancer is treated with its innovative immune cell therapies, has just granted Shunxi Holding … Read more

h2o Therapeutics, a digital health start-up, has partnered with AmerisourceBergen, a global healthcare company, to bring Parky to the market – a revolutionary prescription mobile … Read more

Ossium Health, Inc. is thrilled to announce a $3.46M Clinical Stage Research Program (CLIN1) grant from the California Institute of Regenerative Medicine (CIRM)! This grant … Read more

Today, Esaote S.p.A. held its Shareholders’ Meeting in Genoa, culminating in the approval of the company’s financial statements for the year ending 31.12.2022. With this … Read more

Aditum Bio, the biotech investment firm co-founded by former Novartis CEO Joe Jimenez and Dr. Mark Fishman, former President of the Novartis Institutes for BioMedical … Read more

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) recently welcomed a new team member with the granting of non-qualified stock options to purchase an aggregate of 17,800 shares … Read more

Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing innovative treatments to combat progressive retinal diseases, will be participating in the H.C. Wainwright BioConnect … Read more

Gameto, a female-led biotech company aiming to revolutionize the female reproductive journey, is pleased to announce the addition of Teri Loxam as its inaugural Chief … Read more

Mesoblast Limited, a global pioneer in developing innovative allogeneic cellular medicines for inflammatory diseases, has released its quarterly activity report for the period ending March … Read more

On April 28, Daewoong Pharmaceutical, headed by CEO Jeon Sengho and Lee Chang-jae, made a groundbreaking announcement: they had just signed a Global License Agreement … Read more

CEL-SCI Corporation, a Phase 3 cancer immunotherapy company, is pleased to announce the pricing of its public offering of 794,117 shares of common stock at … Read more

Hillstream BioPharma, Inc. (Nasdaq: HILS) is thrilled to announce the launch of an underwritten public offering of 5,300,000 shares of its common stock. With each … Read more

Bionomics Limited, a clinical-stage biopharmaceutical company, is pleased to announce the successful completion of its randomized, double-blind, placebo-controlled, multi-center Phase 2b ATTUNE clinical trial of … Read more

The U.S. Food and Drug Administration (FDA) has granted approval to VOWSTTM (fecal microbiota spores, live-brpk) – formerly known as SER-109 – a revolutionary microbiota-based … Read more

Shoulders Innovations Inc. (SI) is proud to announce that it has received a first notice of allowance from the United States Patent and Trademark Office … Read more

Arbutus Biopharma Corporation (Nasdaq: ABUS) unveiled groundbreaking clinical and preclinical data for two of its most promising antiviral therapies: AB-729, an RNAi therapeutic, and AB-161, … Read more

Tampa General Hospital’s Executive Vice President and Chief Information Officer (CIO), Scott Arnold, has been recognized for his leadership in Health Care Information Technology (HIT) … Read more

Antengene Corporation Limited (SEHK: 6996.HK), a pioneering biopharmaceutical company dedicated to developing groundbreaking treatments for cancer, is proud to announce the results of their Phase … Read more

Baudax Bio, Inc. (NASDAQ: BXRX) announced the pricing of its public offering of 3,478,262 shares of its common stock (or pre-funded warrants in lieu thereof), … Read more

NeoDynamics, Inc., a pioneering MedTech company, is proud to announce the U.S. availability of NEONAVIA – a revolutionary biopsy system utilizing patented pulse technology that … Read more

Junshi Biosciences, a leading biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, is pleased to announce that the interim analysis of … Read more

Medigene AG, a leader in the field of immuno-oncology, will be sharing its latest breakthroughs in T cell immunotherapy for solid tumors at the 20th … Read more

Bristol-Myers Squibb (NYSE: BMY) continues to expand its global cell therapy manufacturing network, today announcing the launch of a new U.S.-based manufacturing facility and operations … Read more

Mindset Pharma Inc., a drug discovery company dedicated to developing novel, optimized medications to address neuropsychiatric and neurological disorders with unmet medical needs, has filed … Read more

Evommune, Inc., a clinical-stage biotechnology company pioneering innovative treatments for inflammatory diseases, has closed a $50 million Series B financing round. Co-led by Arix Bioscience … Read more

Uvax Bio, LLC, a privately held preclinical-stage vaccine company, has achieved a major breakthrough in its HIV vaccine candidates, with preclinical studies showing significantly improved … Read more

60 Degrees Pharmaceuticals (“60P”), a leader in developing and marketing medicines for infectious diseases, is proud to announce that the United States Patent and Trademark … Read more

Oculis Holding AG (Nasdaq: OCS) – a global biopharmaceutical company with the mission to save sight and improve eye care – is proud to announce … Read more

Oxford BioMedica PLC (LSE:OXB) is delighted to announce the appointment of Ms. Leone Patterson as an Independent Non-Executive Director, who will join the Board on … Read more

Novozymes, Inc. kicked off the 2023 financial year with a bang. In the first three months, the company reported an impressive 5% organic sales growth, … Read more

Vektor Medical, creator of the innovative vMap® next-generation arrhythmia mapping technology, is pleased to announce the addition of two new members to its advisory board … Read more

Evelo Biosciences, Inc. (Nasdaq:EVLO) is taking major strides in the biotechnology industry with its unique platform of orally administered inflammation-resolving medicines. This pioneering platform, called … Read more

Micropep Technologies is pioneering the use of micropeptide technology as a safe and efficient alternative to traditional crop protection. This year, their efforts have paid … Read more

MolecuLight Inc., the leading innovator in point-of-care fluorescence imaging, has just published a groundbreaking study in the Journal of Racial and Ethnic Health Disparities: “Skin … Read more

ImmunityBio, Inc. (NASDAQ: IBRX) Executive Chairman and Global Chief Scientific and Medical Officer Patrick Soon-Shiong, M.D., has been invited to deliver the 2023 David Packard … Read more

Santhera Pharmaceuticals and ReveraGen BioPharma, Inc. have just received the green light from the U.S. Food and Drug Administration for the new drug application of … Read more

IDEAYA Biosciences, Inc. (Nasdaq:IDYA) is thrilled to announce the pricing of an underwritten public offering of common stock and pre-funded warrants! IDEAYA is offering 7,439,201 … Read more

Ascentage Pharma (6855.HK) has achieved a major milestone in its global expansion journey – its Global Manufacturing Center has passed a Qualified Person (QP) audit … Read more

OKYO Pharma Limited, a bio-pharmaceutical company developing OK-101 to treat dry eye disease, is proud to announce the activation of the first clinical trial site … Read more

Verona Pharma plc (Nasdaq: VRNA), a clinical-stage biopharmaceutical company dedicated to improving respiratory health, is pleased to announce its financial results for the first quarter … Read more

Today, medical device company FineHeart S.A. is thrilled to announce that its revolutionary FLOWMAKER® has been granted two patents in China by the CNIPA – … Read more

Adcentrx Therapeutics, a biotechnology company dedicated to revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases, has successfully closed a $38 million Series … Read more

iSpecimen Inc. (Nasdaq: ISPC), the leading online global marketplace connecting scientists with healthcare specimen providers for medical research, is proud to announce that CEO Tracy … Read more

Applied Therapeutics, Inc. (NASDAQ: APLT) announced a major agreement to sell over 9.7 million shares of the company’s common stock, as well as pre-funded warrants … Read more

Aclarion Inc., a healthcare technology company, has just released two-year durability data showing improved surgical outcomes for discogenic low back pain (DLBP) surgeries at painful … Read more

Foghorn Therapeutics Inc. (Nasdaq: FHTX) is making strides in the fight against serious diseases with the development of a groundbreaking new class of medicines designed … Read more

Lantheus Holdings, Inc. and POINT Biopharma Global, Inc. have been granted a Fast Track designation by the U.S. Food and Drug Administration for their innovative … Read more

Soligenix, Inc., a late-stage biopharmaceutical company, has taken a significant step forward in its mission to develop and commercialize products to treat rare diseases. The … Read more

Visolis, a company pioneering the union of advanced bioengineering and chemical catalysis to create carbon-negative materials, has announced an exciting partnership with Ginkgo Bioworks (NYSE: … Read more

As we celebrate the one-year anniversary of the launch of Eversense® E3 in the U.S., Ascensia Diabetes Care, the global diabetes care company and maker … Read more

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a groundbreaking developer of adult stem cell therapies for neurodegenerative diseases, has just welcomed Dr. Kirk Taylor to its … Read more

Despite the promise of new medications that can combat acute myeloid leukemia, leukemic cells have a knack for outsmarting the drugs and evading their effects … Read more

Employers are increasingly pushing to get staff back into the office, despite data indicating that remote work remains a priority for employees across the U.S. … Read more

Ocugen, Inc., a biotechnology company dedicated to uncovering, developing, and marketing novel gene and cell therapies, biologics, and vaccines, is proud to present its groundbreaking … Read more

Roche-subsidiary Genentech’s groundbreaking Polivy (polatuzumab vedotin-piiq) has been given the green light by the FDA, as part of a five-drug regimen, to treat patients with … Read more

Friday, Supreme Court Justice Samuel Alito intervened to prevent a Texas court ruling from taking effect, thus preserving access to the widely used abortion pill … Read more

Thursday marked the launch of Abdera Therapeutics, a West Coast-based biotech firm that is revolutionizing the world of precision radiopharmaceuticals. With a whopping $142 million … Read more

BeiGene scored a major success on Thursday, with the announcement that its Phase III trial for tislelizumab had yielded positive results for patients with a … Read more

IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) is proud to announce the successful completion of a single-site study utilizing the ProSense® System, a minimally-invasive cryoablation … Read more

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) is thrilled to announce that its senior management team will be taking part in a series of … Read more

RetinAI Medical AG, the leader in clinical and imaging data management software and advanced analytics using artificial intelligence (AI) for ophthalmology, is thrilled to announce … Read more

At the 2023 American Academy of Neurology (AAN) Annual Meeting in Boston, Massachusetts, AbbVie (NYSE: ABBV) presented the results of their successful Phase 3 ELEVATE … Read more

Windtree Therapeutics, Inc. (formerly known as Discovery Laboratories, Inc.), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, is pleased to announce the … Read more

Ondine Biomedical, a Canadian life sciences company, has made a breakthrough in the development of photodisinfection for food processing. A proof-of-concept study presented on 12 … Read more

Aditxt, Inc. (NASDAQ: ADTX) is proud to announce the signing of an asset purchase agreement with Cellvera, Ltd. that grants them a 50% stake in … Read more

Twist Bioscience Corporation (NASDAQ: TWST) is proud to announce a collaboration with Astellas Pharma US, Inc. (TSE: 4503, President and CEO: Naoki Okamura.), which will … Read more

Paragonix Technologies Inc., a leader in organ preservation technology and research, has presented groundbreaking new data on how their Paragonix SherpaPak Cardiac Transport System can … Read more

Visus Therapeutics Inc., a clinical-stage pharmaceutical company, has achieved a major milestone in its endeavor to develop therapies for eye conditions. The company has reported … Read more

Cantex Pharmaceuticals Inc. and Michigan Medicine have joined forces to launch a groundbreaking clinical study that has the potential to save lives. This randomized, double-blind, … Read more

DEXIS is proud to announce FDA 510(k) Clearance for its revolutionary dental findings AI on 2D intraoral X-ray images. The next generation of DEXIS software, … Read more

Xcelerate, Inc. (OTCQB:XCRT) has taken a major step towards protecting the groundbreaking technology behind its surgical tools with targeting guidance. The company has filed two … Read more

PLT Health Solutions, Inc. is thrilled to announce its recent partnership with Nano Pharmaceuticals Labs, LLC, making it possible to offer its cutting-edge portfolio of … Read more

Gamida Cell Ltd., a leader in the field of cell therapy, has just announced the pricing of an underwritten public offering of 17,500,000 ordinary shares … Read more

Direct Biologics LLC, a late-stage biotechnology company utilizing its regenerative medicine platform with extracellular vesicles (EVs) secreted from bone marrow-derived mesenchymal stem cells, is pleased … Read more

Myrtelle Inc. has made a breakthrough in its quest to develop transformative treatments for neurodegenerative diseases. At the 6 month post-treatment time point, early data … Read more

At the AACR Annual Meeting 2023 in Orlando, Purple Biotech, a clinical-stage company developing first-in-class therapies that address tumor immune evasion and drug resistance, presented … Read more

Panbela Therapeutics Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company, is proud to announce a poster presentation that will be featured at the American Association … Read more

Enlivex Therapeutics Ltd. (Nasdaq: ENLV) is thrilled to announce that the U.S. Patent and Trademark Office has issued a Notice of Allowance for its patent … Read more

At the 2023 Anxiety and Depression Association of America (ADAA) Conference in Washington, D.C., VistaGen Therapeutics, Inc. unveiled new research that further supports the proposed … Read more

Schrödinger, Inc. (Nasdaq: SDGR) is revolutionizing the way drugs and materials are discovered with its physics-based computational platform. On April 14, 2023, the company granted … Read more

Resilia Pharmaceuticals, Inc. is delighted to announce the return of its beloved Solace® Eczema Cream, now available on Amazon®! Previously only available with a prescription, … Read more

SeaStar Medical Holding Corporation (Nasdaq: ICU) has officially activated Good Samaritan Regional Medical Center in Corvallis, Oregon as the first clinical site in its groundbreaking … Read more

Athersys, Inc. (Nasdaq: ATHX) today announced that is has reached an agreement to purchase 3,685,000 shares of its own common stock (or common stock equivalents) … Read more

Tessera Therapeutics, the biotechnology company revolutionizing the genetic medicine space with its Gene Writing™ technology, has announced the appointment of Cynthia M. Patton as its … Read more

DARE Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovations, has just announced the publication of safety and acceptability results in Climacteric, the official … Read more

Simulations Plus, Inc. (Nasdaq: SLP) is thrilled to announce that its DILIsym® software platform has been granted another year of licensing by the U.S. FDA. … Read more

Ocelot Bio, Inc., a clinical-stage biopharmaceutical company with a focus on developing treatments for the complications of end-stage liver disease (ESLD), is proud to announce … Read more

Xenocor, the creator of Saberscope, the world’s first true HD, fog-free, articulating, single-use laparoscope, has just closed a $10 million Series A round of funding, … Read more

Lisata Therapeutics, Inc. (Nasdaq: LSTA) and WARPNINE Incorporated have joined forces to pioneer a new trial to treat advanced pancreatic ductal adenocarcinoma (PDAC). The iLSTA … Read more

ProSomnus, Inc. (NASDAQ: OSA), a leader in the field of medical devices for the treatment of Obstructive Sleep Apnea (OSA), is proud to announce the … Read more

Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company pioneering groundbreaking antiviral therapeutics, today revealed the results of the final multiple-dose cohort in the Phase 1a … Read more

Spectral Medical Inc., a theranostic company focused on advancing therapeutic options for sepsis and septic shock, has recently announced positive results from EUPHAS-2, an observational … Read more

At the American Association for Cancer Research (AACR) Annual Meeting, Transgene (Euronext Paris: TNG), a biotech company with a mission to develop virus-based immunotherapies to … Read more

Glycotope GmbH, a biotechnology company utilizing an innovative platform technology to develop antibodies against proteins carrying tumor-specific carbohydrate structures, will present its glyco-engineered cell lines … Read more

Genmab A/S (Nasdaq: GMAB) and argenx (Euronext & Nasdaq: ARGX) have joined forces to revolutionize the way we treat immunological and oncological diseases. Through this … Read more

Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI) is pleased to announce the release of its financial and operational results for the first quarter ended March … Read more

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is excited to present a poster at the American Association for Cancer Research (AACR) annual meeting in … Read more

In 2023, Henlius’ commercialization strategy has paid off, as their revenue skyrocketed by 97.2% to RMB995.7 million. The company has leveraged its innovative biopharmaceuticals and … Read more

At the American Association for Cancer Research (AACR) Annual Meeting 2023, Cellectis, a clinical-stage biotechnology company aiming to develop life-saving cell and gene therapies, presented … Read more

BioNxt is thrilled to announce that it has acquired cutting-edge coating and cutting equipment to expand its commercial manufacturing capabilities at its Vektor Pharma TF … Read more

CathVision, a medical technology company developing state-of-the-art electrophysiology solutions to optimize clinical decision-making in the EP lab, is proud to announce the enrollment of the … Read more

Medivir AB, a leading pharmaceutical company focused on developing cutting-edge treatments for cancer, is presenting a poster today at the AACR Annual Meeting that highlights … Read more

Bio-Thera Solutions, Ltd. (SH: 688177) is set to present a poster at the 2023 AACR Annual Meeting in Orlando, Florida, featuring Phase 1 clinical results … Read more

Alvotech, a global biotech company dedicated to developing and manufacturing biosimilar medicines to benefit patients worldwide, has received a Complete Response Letter (CRL) from the … Read more

Immunis, Inc., a private biotechnology company, has appointed Neil Sahota, a visionary leader in the field of Artificial Intelligence (AI), as its Chief AI Officer. … Read more

Caris Life Sciences® and its partners in the Caris Precision Oncology Alliance™ (POA) are proud to present four studies across 14 tumor types at the … Read more

Curiteva, a Huntsville, AL based technology company, is revolutionizing spinal surgery with the commercial release of its Inspire Porous PEEK HAFUSE Cervical Interbody System, recently … Read more

Phase Genomics and Element Biosciences have announced the results of their exciting first collaboration, combining Phase Genomics’ OncoTerra™ cytogenomics platform with Element’s AVITI System for … Read more

MindMed Inc, a clinical stage biopharmaceutical company developing treatments for brain health disorders, is pleased to announce the positive topline data from a double-blind, investigator-initiated … Read more

Catalent, Inc. – the leading innovator in developing and providing better treatments for patients worldwide – has released a business update for its third fiscal … Read more

Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company dedicated to developing treatments for rare diseases, recently held a Type A Meeting with the United States … Read more

Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL), a pharmaceutical company focused on developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies, is thrilled to announce … Read more

At the AACR Annual Meeting 2023, PreOmics GmbH unveiled the revolutionary BeatBox-based FFPE workflow, revolutionizing the world of tissue proteomics. This ground-breaking new workflow simplifies, … Read more

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines, has … Read more

Kazia Therapeutics Limited, an oncology-focused drug development company, is pleased to announce that it has regained compliance with the minimum bid price requirement of the … Read more

Merck & Co. and XtalPi Inc., a groundbreaking pharmaceutical technology company, have joined forces to publish a study on how AI and automation can be … Read more

Q Biomed Inc. (OTCQB: QBIO) is thrilled to announce that their asset Uttroside B has been granted a patent in the United States and a … Read more

M2Gen, the leading oncology bioinformatics company, is transforming the medical product discovery process with its revolutionary lifetime-consented clinicogenomic data. To mark this new era of … Read more

Ginkgo Bioworks (NYSE: DNA) and the Institut National de la Recherche Biomédicale (“INRB”), the national medical research organization of the Democratic Republic of the Congo … Read more

The MAGMA trial, sponsored by the National Heart, Lung, and Blood Institute (NHLBI), was conducted to evaluate the effects of Spironolactone, a generic drug, on … Read more

The U.S. Food and Drug Administration (FDA) has granted Horizon Therapeutics plc (Nasdaq:HZNP) approval to update the Indications and Usage section of the TEPEZZA label, … Read more

Minghui Pharmaceutical, Inc. is thrilled to share top line results from its Phase 2 study of MH004 Cream, a topical cream of a pan-JAK inhibitor, … Read more

Akari Therapeutics, Plc (Nasdaq: AKTX) is excited to attend ARVO 2023, the annual meeting of The Association for Research in Vision and Ophthalmology. The late-stage … Read more

Altamira Therapeutics (“Altamira” or the “Company”) (Nasdaq:CYTO) is revolutionizing the field of mRNA (messenger ribonucleic acid) applications with its innovative SemaPhore™ peptide-based nanoparticle technology. This … Read more

Eterna Therapeutics Inc. (Nasdaq: ERNA) is excited to announce that it has entered into an agreement with Lincoln Park Capital Fund, LLC (“LPC”) for up … Read more

Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company, has just announced that it has regained the North American rights to develop and commercialize … Read more

eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) is proud to announce a groundbreaking collaboration between their leading cancer treatment and Stanford Medicine. Jennifer Caswell-Jin, M.D., Assistant Professor … Read more

V007 is a groundbreaking Phase 3 trial that is set to revolutionize dialysis for those suffering from ESRD in the United States. 240 patients were … Read more

TREVENTIS Corporation, a privately held biotechnology company, is thrilled to announce that it has entered an exciting option, collaboration, and license agreement with Takeda to … Read more

Clene Nanomedicine, Inc., a revolutionary clinical-stage biopharmaceutical company wholly owned by Clene Inc. (NASDAQ: CLNN), is proud to announce three presentations at the upcoming 2023 … Read more

Kyowa Kirin Inc., a global specialty pharmaceutical company based in Japan, is delighted to introduce Steve Schaefer as President of North America, effective immediately. Mr. … Read more

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA), a clinical stage biopharmaceutical company developing pioneering treatments for renal and inflammatory diseases, is delighted to announce that its Co-Founder, … Read more

Today marks the launch of 32 Stripes, a revolutionary new recruitment business specialising in solving recruitment problems for senior and technical roles in the informatics … Read more

Shockwave Medical, Inc. (NASDAQ: SWAV) has completed its acquisition of Neovasc Inc., a major leap forward in its mission to revolutionize the treatment of severely … Read more

Xenetic Biosciences Inc. (NASDAQ:XBIO) is excited to announce that it has entered into an innovative Research Funding and Option Agreement with The Scripps Research Institute … Read more

Jaguar Health Inc (Nasdaq:JAGX) has announced that its pivotal Phase 3 OnTarget clinical trial of crofelemer for prophylaxis of diarrhea in adult cancer patients receiving … Read more

RenovoRx Inc., a biopharmaceutical company focused on localized treatment of solid tumors, is proud to announce the addition of Leesa Gentry to the Company’s executive … Read more

Legend Biotech Corporation, a global biotechnology leader in developing, manufacturing and commercializing novel treatments for life-threatening diseases, today announced the appointment of Mythili Koneru, M.D., … Read more

Mission Bio Inc. and Fulgent Genetics, Inc. (NASDAQ: FLGT) have entered into a groundbreaking partnership to bring the power of single-cell multi-omics to the Fulgent … Read more

Karius® and eGenesis, Inc. are partnering to revolutionize the treatment of organ failure through xenotransplantation. Combining Karius’ liquid biopsy platform with eGenesis’ human-compatible organs and … Read more

Quadriga BioSciences is thrilled to announce that the first subject has been dosed in their groundbreaking Phase 2 clinical study of QBS10072S (QBS72S), a potential … Read more

LyGenesis and Imagine Pharmaceuticals have come together to create a revolutionary collaboration to develop life-changing cell therapies for patients with type 1 diabetes. By combining … Read more

In 2015, the U.S. Food and Drug Administration approved the monoclonal antibodies daratumumab and elotuzumab for treating multiple myeloma (MM). However, most patients’ disease eventually … Read more

A groundbreaking new study from Children’s Hospital of Philadelphia (CHOP) has revealed that a special class of human T cells, which are responsible for both … Read more

Applied DNA Sciences, Inc. (NASDAQ: APDN) has made headlines today by having their CertainT® supply chain traceability platform featured in an article on the home … Read more

After a week of relative quiet, the FDA is gearing up for a busy April. This month, the agency will decide on the approval of … Read more

YDS Pharmatech, Inc. scientists have made a revolutionary breakthrough in the field of PROTACs! By introducing a Generative Diffusion Model (GDM) for sampling ensembles of … Read more

Sobi® is delighted to announce a simplification of the contractual economics for nirsevimab. Last January, the company completed the acquisition of Synagis® (palivizumab) from AstraZeneca … Read more

Verona Pharma plc (Nasdaq: VRNA) is thrilled to announce that its development partner, Nuance Pharma, has successfully dosed the first subject in the ENHANCE – … Read more

HCmed Innovations Co., Ltd., a contract development and manufacturing organization (CDMO), is delighted to announce the appointment of Gunilla Petersson, Ph.D. as its new Chief … Read more

Syncell, a leading biotech company pioneering in platforms for hypothesis-free spatial proteomics, is excited to be exhibiting and presenting a poster at the upcoming AACR … Read more

GC Genome Corporation, a leader in genomic diagnostics, has just published a study in Radiation Oncology Journal proving the effectiveness of cell-free DNA monitoring to … Read more

Icentia Inc. is delighted to announce that CardioSTAT, its ambulatory, continuous ECG monitoring solution relying on a wire free, single-use recorder, has received FDA 510(k) … Read more

Insmed Incorporated, a global biopharmaceutical company dedicated to improving the lives of those with serious and rare diseases, is thrilled to announce the granting of … Read more

Antheia, the revolutionary pharmaceutical ingredient manufacturer, is proud to announce the appointment of John Nicols to its Board of Directors. Joining the esteemed Board alongside … Read more

EvoEndo®, Inc., a medical device company revolutionizing Unsedated Transnasal Endoscopy (TNE), has made key leadership changes that will further propel their innovative mission. By creating … Read more

Thermo Fisher Scientific, the global leader in science and innovation, is proud to announce a new development in its Bourgoin, France site – it is … Read more

electroCore, Inc. (the “Company”) (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce that it has received a license to import, … Read more

Spectral Medical Inc. (TSX: EDT) invites investors to join in on the 2023 Investor Update conference call to learn more about the latest developments of … Read more

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced a new addition to its Board of Directors: Tim Walbert. The company is also noting the upcoming departure … Read more

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is thrilled to announce the receipt of additional non-dilutive funds from Radium Capital (Radium) in the amount of … Read more

Peptilogics, a clinical stage biotechnology company, has successfully completed the enrollment of a Phase 1b trial of their novel therapeutic, PLG0206, to treat Periprosthetic Joint … Read more

ZSFab, Inc., a 3D-printing medical device company, is thrilled to announce a milestone achievement – the successful use of the ZSFab Cervical Interbody System in … Read more

Astcyte Pharmaceuticals Inc. is thrilled to announce the commencement of a Phase 1B study of its lead candidate, AST-004. This adaptive-design clinical study, to be … Read more

iOmx Therapeutics AG, a biopharmaceutical company at the forefront of developing cutting-edge cancer immunotherapy treatments, today announced a major milestone with the dosing of the … Read more

Everest Medicines, a biopharmaceutical company dedicated to the development, manufacturing, and commercialization of innovative medicines and vaccines, is making significant progress in the global fight … Read more

Nox Medical is revolutionizing the way endophenotypes of sleep-disordered breathing are determined with the recent patent of their innovative Nox RIP technology, allowing for the … Read more

AstraZeneca’s Imfinzi (durvalumab) and Lynparza (olaparib) have proven to be a powerful combination in treating advanced high-grade epithelial ovarian cancer, according to interim results of … Read more

Ochre Bio is thrilled to welcome two esteemed professionals to its team. David Coughlan, PhD has been appointed as Vice President of Translational Development, and … Read more

Curis, Inc. (NASDAQ: CRIS), a biotechnology company dedicated to creating innovative treatments for cancer, has granted a new employee 135,450 shares of its common stock … Read more

Nona Biosciences, a subsidiary of HBM Holdings Limited, has joined forces with ExeVir Bio in a collaboration that promises to revolutionize the development of treatments … Read more

Today, Thursday, April 6, 2023, Sensorion (FR0012596468 – ALSEN) – a pioneering clinical-stage biotechnology company that specializes in gene therapies for the inner ear – … Read more

Sharp Technology, Inc., a revolutionary medical device and drug delivery company that develops cutting-edge syringe products, is proud to provide a shareholder update from Chief … Read more

Solvay, a pioneering company in science and materials, is partnering with Ginkgo Bioworks to unlock the potential of synthetic biology and create more sustainable chemicals … Read more

Arkuda Therapeutics, a biotechnology company on the cutting edge of lysosomal biology and neuronal health, is pleased to announce the appointment of Arkuda co-founder Duane … Read more

Zimmer Biomet Holdings, Inc. is proud to announce that its leadership team will be presenting at the Needham Virtual Healthcare Conference on Tuesday, April 18th … Read more

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) and Kindeva Drug Delivery have made a breakthrough in the fight against substance abuse: the selection of the AVERSA™ formulation to take … Read more

Enzolytics has made impressive progress in its mission to create Monoclonal Antibodies to treat animals, filing a patent application to protect its discovery of conserved … Read more

Mosaic Therapeutics, Ltd., a pioneering oncology therapeutics company, is pleased to announce the close of its $28 million series A funding round and the appointment … Read more

Biogen Inc. (Nasdaq: BIIB) is pleased to announce the appointment of Adam Keeney, Ph.D., as its new Executive Vice President and Head of Corporate Development. … Read more

Lannett Company, Inc. (NYSE: LCI) is dedicated to providing patients and customers with safe, affordable, effective, and life-enhancing generic pharmaceutical products. To ensure continued success … Read more

Sobi North America and Swedish Orphan Biovitrum AB (Sobi®) have jointly announced the publication of findings from a pivotal phase 2 study in the Annals … Read more

Mainz Biomed, a molecular genetics diagnostic company that specializes in the early detection of cancer, is proud to announce that ColoAlert®, their efficient and easy-to-use … Read more

Beactica Therapeutics AB and Oscotec Inc. have mutually decided to part ways and end their collaboration for the research and development of innovative anti-cancer drugs. … Read more

The 28th ADQI workgroup has acknowledged SphingoTec’s penKid as a reliable functional biomarker that can accurately detect cases of SA-AKI. Sepsis is an extremely serious … Read more

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) is pleased to announce two new additions to its Board of Directors: Hans Arwidsson as Chairman, and Alan Raffensperger as Board Member. … Read more

PHC Corporation and NovaScan, Inc. are excited to announce a collaboration to explore the potential of MarginScanTM, an investigational “ex vivo” medical device that could … Read more

Today, iNtRON Biotechnology has made a groundbreaking announcement: its PHAGERIA® platform technology has proven successful in treating cancer using P18-BE3CRC, a unique drug candidate consisting … Read more

Addex Therapeutics, a cutting-edge pharmaceutical company specializing in allosteric modulation-based drug discovery and development, has released data showing the promising potential of dipraglurant in treating … Read more

Relief Therapeutics, a biopharmaceutical company dedicated to developing and commercializing innovative, patent-protected products for select specialty and rare diseases, is pleased to announce an upcoming … Read more

Skanska has signed a USD 111M (SEK 1.2 billion) contract amendment with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, … Read more

Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II), a company active in cancer monitoring, is thrilled to announce the signing of a commercial partnership agreement with the Italian company, IT … Read more

Campbell Neurosciences, a spin off company of Therapeutic Solutions International (TSOI), has announced exciting new data, covered by its filed patents, that shows CampbellCell universal … Read more

ContraFect Corporation, a clinical-stage biotechnology company, has announced the launch of a Phase 1b/2 trial of exebacase in the context of a DAIR procedure for … Read more

Evergreen Discovery and Orbit Discovery Ltd have joined forces to revolutionize the treatment of cancer. Through their innovative collaboration, they are developing radiopharmaceuticals that use … Read more

PharmaJet, in collaboration with Gennova Biopharmaceuticals Limited, has submitted data for their mRNA-based Omicron specific Covid-19 booster shot to the office of the Drug Controller … Read more

Kiromic BioPharma, Inc. (NASDAQ: KRBP) is pleased to announce the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration … Read more

Panbela Therapeutics Inc., (Nasdaq: PBLA) is thrilled to announce a new research collaboration with the esteemed Johns Hopkins University School of Medicine. This exciting venture … Read more

Alzamend Neuro, Inc., is pleased to announce that the US Food and Drug Administration has given the green light for its Phase I/IIA Trial Under … Read more

Abcuro, Inc., a clinical-stage biotechnology company, is taking a major step forward in the fight against autoimmune diseases and cancer with the initiation of a … Read more

The Wyss Center for Bio and Neuroengineering is delighted to welcome Prof. Dr. med. Erwin Böttinger as its new CEO. With a strong background in … Read more

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) is thrilled to announce that it has inked an exclusive license agreement with Takeda, granting them exclusive … Read more

Psilera is delighted to mark a major preclinical achievement with a perfect record of accomplishment. Its first group of custom-made drug candidates have all been … Read more

Galapagos NV (Euronext & NASDAQ: GLPG) and NovAliX have joined forces in a strategic collaboration, aiming to accelerate innovation, reduce risks, and shorten drug development … Read more

Creative Proteomics is proud to announce the launch of its BioID platform, a revolutionary new tool for exploring protein-protein interactions and pinpointing the exact targets … Read more

XOMA Corporation (NASDAQ: XOMA) is excited to announce its acquisition of the commercial payment and milestone rights for IXINITY® [coagulation factor IX (recombinant)], a product … Read more

CD Genomics is a leading provider of cutting-edge genomic services. Their latest addition, TCR-seq, is an innovative and powerful tool that allows researchers to quickly … Read more

Element Materials Technology has unveiled an exciting new global offering of Extractables and Leachables (E&L) services, combining the expertise of over 75 professionals across its … Read more

Smart Immune SAS, a clinical-stage biotechnology company, has been selected by the European Innovation Council (EIC) to receive €17.5 million in funding to further the … Read more

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)(“Microbix®” or the “Company”), a life sciences innovator, manufacturer, and exporter, is pleased to announce the results of the … Read more

Alaunos Therapeutics, Inc. (Nasdaq: TCRT), a leading T-cell receptor (TCR) cell therapy company, is pleased to announce the appointment of Robert J. Hofmeister, PhD, MS, … Read more

AAD, the innovative developer of rapid diagnostic systems, is taking a major step forward in its efforts to provide fast and accurate results for hematology … Read more

CoreLink, LLC, a leader in the design and production of advanced spinal implant systems, is thrilled to announce that the U.S. Food and Drug Administration … Read more

Akari Therapeutics, Plc (Nasdaq: AKTX) is thrilled to announce that regulatory authorities in Poland and the U.K. have officially approved amendments to the company’s Investigational … Read more

Kala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company devoted to the development and commercialization of treatments for rare and serious eye diseases, is proud to announce … Read more

PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company working to improve surgical outcomes, has announced the pricing of its underwritten public offering of 14,660,000 ordinary … Read more

WAVE Life Sciences Ltd. (Nasdaq: WVE) is thrilled to announce that their President and Chief Executive Officer, Dr. Paul Bolno, MD, MBA, is scheduled to … Read more

Achieve Life Sciences Inc. (Nasdaq: ACHV) is proud to announce that the final study follow-up visit for the last subject enrolled in the Phase 3 … Read more

Cardiovascular, metabolic, and neurological diseases, such as ischemic heart disease, stroke, diabetes, and Parkinson’s disease, cause immeasurable suffering and are responsible for millions of deaths … Read more

Debbie’s Dream Foundation: Curing Stomach Cancer (DDF) returned to Washington, DC, this March for the 11th Annual Stomach Cancer Capitol Hill Advocacy Day. For the … Read more

Hansa Biopharma, a leader in enzyme technology for rare immunological conditions, has just been granted access and reimbursement by the Spanish Minister of Health for … Read more

Metabolon, Inc., the world-renowned leader in metabolomics solutions for research, diagnostics, therapy development, and precision medicine, is proud to announce that its metabolomics platform and … Read more

Monopar Therapeutics has made the difficult decision to discontinue its Phase III trial of Validive, its lead candidate, which had been in development to treat … Read more

Antengene Corporation Limited (SEHK: 6996.HK) proudly released its financial results for the full year of 2022 and shared its remarkable accomplishments since the start of … Read more

Celularity Inc., a biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, is proud to announce its exclusive distribution agreement with AD Ports Logistics … Read more

Covant Therapeutics, a pioneering covalent drug discovery company, has recently inked an exclusive research collaboration and licensing agreement with Boehringer Ingelheim to spearhead the development … Read more

Codagenix, Inc., a clinical-stage synthetic biology company, is proud to announce the appointment of Kimber Poffenberger, Ph.D., as Chief Strategy Officer. Dr. Poffenberger will be … Read more

Lucira Health, Inc., a medical technology company, is excited to announce the launch of its revolutionary Lucira COVID-19 & Flu Home Test in the United … Read more

Freenome, a pioneering biotech company, is thrilled to announce that Renown Health has joined forces as a partner for the Sanderson Study. This highly anticipated … Read more

Sirius Medical, the leader in surgical marker navigation, is pleased to announce the successful closure of their Series B Round, raising a total of 12 … Read more

Q’Apel Medical Inc. has revolutionized the treatment of acute ischemic stroke with the Walrus Balloon Guide Catheter (BGC). Since 2019, the Walrus BGC has been … Read more

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has recently celebrated the successful conclusion of its “Ken Griffin Alpha-synuclein Imaging Competition,” a groundbreaking $10-million … Read more

BioSig Technologies, Inc. (NASDAQ: BSGM) is proud to welcome Edwin Wang to its Advisory Board. The cutting-edge digital signal processing company is revolutionizing intracardiac signal … Read more

BIORCHESTRA, a biotherapeutics company focused on providing life-changing treatments to those suffering from rare and degenerative diseases within the Central Nervous System (CNS), has announced … Read more

Aadi Bioscience, Inc. (NASDAQ: AADI) is delighted to welcome Mohammad Hirmand, M.D. to its Board of Directors. Dr. Hirmand brings more than two decades of … Read more

Anika Therapeutics, Inc. (NASDAQ: ANIK) is pleased to announce that it has filed its preliminary proxy materials with the Securities and Exchange Commission (“SEC”) in … Read more

At the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer, Agenus Inc. presented results from a cohort of 24 evaluable patients in an … Read more

BPGbio Inc., an AI-powered biopharma on a mission to revolutionize biology for the benefit of humanity, has teamed up with debra of America to launch … Read more

The AIDS Clinical Trials Group (ACTG) is excited to announce the publication of “Perspectives on Adherence from the ACTG 5360 MINMON Trial: A Minimum Monitoring … Read more

Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving nearly 38 million members nationwide, is thrilled to announce the appointment of Mostafa Kamal as president … Read more

Today, Therapeutic Solutions International’s spinoff company, Campbell Neurosciences, announced the appointment of Thomas Ichim, Ph.D., as President and Chief Executive Officer, replacing Kalina O’Connor, the … Read more

Novartis’ Kisqali (ribociclib) has been proven to reduce the risk of recurrence in early breast cancer, according to the results of the Phase III NATALEE … Read more

Jaguar Health, Inc. (NASDAQ:JAGX) is inviting investors to join a live webcast on March 27, 2023, to review the fourth-quarter 2022 financials and get a … Read more

Kymanox Corporation, a specialized professional services provider dedicated to the life science industry, has just acquired Agilis Consulting Group. Through their expertise in human factors, … Read more

Roche Canada is pleased to announce the approval of COLUMVI® (glofitamab for injection) by Health Canada for the treatment of adult patients with relapsed or … Read more

At the Society of Gynecological Oncology (SGO) Annual Meeting 2023, Aadi Bioscience, Inc. (NASDAQ: AADI) presented data from its PRECISION 1 and AMPECT trials that … Read more

ImmunoGen, Inc. (Nasdaq: IMGN) is proud to present final overall survival data and an evaluation of sequence of therapy in the pivotal SORAYA trial of … Read more

Today, Everest Medicines (HKEX 1952.HK) – a biopharmaceutical company focused on transforming the pharmaceutical landscape in Greater China and beyond – has announced a huge … Read more

Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D.) is thrilled to announce that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio … Read more

The UK’s National Institute for Health and Care Excellence (NICE) has given the go-ahead for PTC Therapeutics’ Upstaza (eladocagene exuparvovec) to be used in the … Read more

AbbVie celebrated a double victory on Thursday, after announcing the successful completion of two clinical trials. The Phase III INSPIRE study revealed that the drug … Read more

Relmada Therapeutics has announced a crucial modification to its clinical assessment of REL-1017 as a potential supplemental therapy for major depressive disorder (MDD), following the … Read more